Please login to the form below

Not currently logged in
Email:
Password:

Fishawack expands its teams

Fishawack has appointed two new industry experts to its group: Linda Harris and Jo Jarvis

Fishawack has appointed two new industry experts to its group: Linda Harris and Jo Jarvis.

Industry veteran Linda Harris joined the US team in September 2010 as vice president, Stakeholder and Thought Leader Strategies.

The appointments follow Fishawack's recruitment of eight new starters in March.

Linda's 30 years of experience in pharma sales and marketing includes positions at Sandoz, Novartis, and Wyeth (now Pfizer), where she was assistant vice president of the Opinion Leader Relations department.

In addition, Jo Jarvis recently joined the Fishawack UK team as director, Stakeholder Strategies. Jo was at Wyeth for more than 20 years, most recently as head of Advocacy.

Building on their working relationship, the two will be serving as faculty at the upcoming Centre for Business Intelligence conference on May 24-25 in San Diego, titled 'Inaugural West Coast Forum on Defining Compliant and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) to Support Product Development and Commercialisation.'

An online stakeholder relations portal will also be developed and executed later this year.

According to Fishawack CEO, Oliver Dennis: "There is an unfulfilled need for a standardised approach to managing these important relationships, and we're excited to be able to pioneer these services through the unique insight of our experienced industry professionals and in-house experts."

19th April 2011

Share

Subscribe to our email news alerts

PMHub

Add my company
The Creative Engagement Group

We create experiences that inspire lasting change. Exceptional experiences that engage people, change mindsets and behaviour, enrich cultures, increase skills...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...